Paul’s experience spans more than 25 years in the commercialization of technologies, strategy & business development, M&A, and in selecting, investing and building LifeScience companies; Paul has successfully led investment rounds in several Life science companies for investment funds and family offices.
Frans van Dalen,
Frans’ experience spans more than 30 years in the (bio)pharmaceutical industry. He has held staff / senior managerial positions in Strategic Program Development, QA / QP, Project Management, R&D and Regulatory Affairs. Since 1992, he was one of the partners that built the Synthon group of companies (1,500 FTEs at 9 strategic locations globally) and was involved in the R&D, Regulatory Affairs, manufacturing and commercialization of generic medicines, biosimilars and new biological entities.